Opportunity Information: Apply for PAR 19 297

Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional), Funding Opportunity Number PAR 19-297, is a National Institutes of Health (NIH) discretionary grant opportunity designed to support collaborative, multi-site clinical studies focused on understanding mental illnesses rather than testing new treatments. The central idea is to fund research that can answer important clinical and mechanistic questions about mental health by bringing together two or more research sites under a shared, single protocol. This multi-site structure is meant to make studies stronger and more generalizable by increasing total sample size, speeding up recruitment, and improving participant diversity and representation across different communities and settings.

The scientific scope emphasizes clinical studies in areas such as mental health genetics, biomarker discovery or validation, and deeper characterization of mental illnesses. Examples include research on psychopathology and the ways symptoms present and change across individuals, as well as studies of neurodevelopmental trajectories that track how risk, symptoms, and related biological or behavioral measures evolve over time. The announcement also highlights that studies may address mental illnesses in the context of HIV/AIDS, recognizing that mental health conditions can intersect with HIV-related factors and outcomes in clinically meaningful ways. While the FOA allows clinical trials to be optional, it is explicit that the purpose is not treatment development and not efficacy or effectiveness testing; in other words, this is not the right mechanism for projects whose primary goal is to determine whether an intervention works.

A defining feature of this opportunity is the expectation of true collaboration across sites. Applicants are expected to use a common protocol and aligned methods across participating locations so that data can be pooled and compared cleanly. When a project involves many sites, NIH expects that one application will function as a coordinating R01, responsible for centralized duties such as data management and other administrative coordination needed to keep the overall study consistent and on track. This coordinating structure is intended to reduce fragmentation, maintain data quality, and ensure that all sites adhere to the same study procedures, measures, and governance.

Eligibility is broad and includes many types of organizations that can carry out clinical research. In addition to standard applicants such as public and private institutions of higher education, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses) and small businesses, and multiple levels of government (state, county, city/township, special district, and independent school districts), the FOA explicitly includes tribal entities and housing authorities as eligible applicants. It also calls out a wide range of additional eligible applicants and partner-ready institutions, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions. Notably, non-domestic (non-U.S.) entities (foreign organizations) are also listed among eligible applicants, which can support international collaboration when scientifically justified.

From an administrative standpoint, the award mechanism is the NIH R01 research project grant, categorized under Health, with CFDA number 93.242. The FOA was created on 2019-06-10, and the original closing date listed in the source information is 2022-09-07. The source data does not specify an award ceiling or the expected number of awards, so applicants typically would look to NIH institute guidance, budget justification norms for R01s, and the specific scientific and operational needs of a multi-site study when planning project scope and budget.

Overall, this opportunity is aimed at teams that need a coordinated, multi-site approach to answer clinically relevant questions about mental illness using shared protocols, with particular encouragement for work in genetics, biomarkers, and developmental or phenomenological studies of psychopathology, including when mental health conditions intersect with HIV/AIDS. The best fit projects are those where collaboration is essential to achieve adequate sample size, recruitment speed, or representation, and where the primary goal is to generate robust clinical and biological knowledge rather than to test whether a treatment works.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.242.
  • This funding opportunity was created on 2019-06-10.
  • Applicants must submit their applications by 2022-09-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 19 297

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the funding opportunity?

This opportunity is the NIH discretionary grant titled Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional), Funding Opportunity Number PAR 19-297.

What is the main purpose of PAR 19-297?

The purpose is to support collaborative, multi-site clinical studies that improve understanding of mental illnesses by answering important clinical and mechanistic questions using a shared, single protocol across two or more research sites.

Is this opportunity meant for testing new treatments or interventions?

No. The FOA is explicit that it is not intended for treatment development and not for efficacy or effectiveness testing. Projects whose primary goal is determining whether an intervention works are not considered a good fit based on the description provided.

Are clinical trials required under this FOA?

No. The FOA is described as Clinical Trial Optional, meaning a clinical trial may be included if appropriate, but it is not required based on the information provided.

What kind of study design does NIH expect?

NIH expects a true multi-site design with two or more research sites operating under a shared, single protocol with aligned methods so that data can be pooled and compared cleanly.

Why does the FOA emphasize multi-site collaboration?

The multi-site structure is intended to strengthen studies by increasing total sample size, speeding up recruitment, and improving participant diversity and representation across different communities and settings.

What scientific areas are highlighted as a good fit?

The scope emphasizes clinical studies such as mental health genetics, biomarker discovery or validation, and deeper characterization of mental illnesses.

What types of research questions are examples of a good fit?

Examples described include research on psychopathology (how symptoms present and change across individuals) and studies of neurodevelopmental trajectories that track how risk, symptoms, and related biological or behavioral measures evolve over time.

Does the FOA allow studies that involve HIV/AIDS?

Yes. The announcement highlights that studies may address mental illnesses in the context of HIV/AIDS, recognizing clinically meaningful intersections between mental health conditions and HIV-related factors and outcomes.

What does "collaborative" mean in this FOA?

Based on the description, "collaborative" means participating sites are expected to use a common protocol and aligned methods, with study procedures, measures, and governance designed so that results can be combined and compared across sites.

How should coordination work when there are multiple sites?

When a project involves many sites, NIH expects that one application will function as a coordinating R01, responsible for centralized duties such as data management and other administrative coordination needed to keep the overall study consistent and on track.

What is the award mechanism for this opportunity?

The award mechanism is the NIH R01 research project grant.

What is the CFDA number and category listed?

The opportunity is categorized under Health with CFDA number 93.242.

Who is eligible to apply?

Eligibility is broad. The FOA includes (among others): public and private institutions of higher education; nonprofits (501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses) and small businesses; multiple levels of government (state, county, city/township, special district, and independent school districts); tribal entities; and housing authorities.

Are specific minority-serving or community-based institutions included?

Yes. The FOA explicitly includes many institution types such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, Hispanic-serving Institutions, HBCUs, TCCUs, faith-based or community-based organizations, regional organizations, eligible federal agencies, and U.S. territories or possessions.

Are non-U.S. (foreign) organizations eligible to apply?

Yes. The description states that non-domestic (non-U.S.) entities (foreign organizations) are listed among eligible applicants, which can support international collaboration when scientifically justified.

How many awards will NIH make and what is the maximum award amount?

The source information provided does not specify an award ceiling or the expected number of awards.

What dates are associated with this FOA?

The FOA was created on 2019-06-10, and the original closing date listed in the source information is 2022-09-07.

What kinds of projects are the best fit overall?

Based on the description, the best fit projects are those where a coordinated, multi-site approach is essential to achieve adequate sample size, recruitment speed, or representation, and where the primary goal is to generate robust clinical and biological knowledge about mental illness rather than to test a treatment.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Port Infrastructure Development Grants

Previous opportunity: FY19 ATC PLC Youth Corps Projects

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 19 297

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 19 297) also looked into and applied for these:

Funding Opportunity
Aging, Driving and Early Detection of Dementia (R01 Clinical Trial Optional) Apply for RFA AG 20 022

Funding Number: RFA AG 20 022
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders (U24 Clinical Trial Not Allowed) Apply for RFA MH 20 215

Funding Number: RFA MH 20 215
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Mechanistic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 Clinical Trial Not Allowed) Apply for RFA NS 19 039

Funding Number: RFA NS 19 039
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Characterization of Marmosets as Models of Aging and Age-Related Diseases (U34 Clinical Trial Not Allowed) Apply for RFA AG 20 007

Funding Number: RFA AG 20 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $225,000
Non-Invasive Neurostimulation in AD/ADRD (R01 Clinical Trial Optional) Apply for PAR 19 298

Funding Number: PAR 19 298
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Institute of General Medical Sciences (NIGMS) Bridges to the Baccalaureate (T34) Apply for PAR 19 299

Funding Number: PAR 19 299
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Country Health Information Systems and Data Use (CHISU) Apply for 7200AA19R00065

Funding Number: 7200AA19R00065
Agency: Agency for International Development
Category: Health
Funding Amount: Case Dependent
National Institute of General Medical Sciences (NIGMS) Bridges to the Doctorate (T32) Apply for PAR 19 300

Funding Number: PAR 19 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service Centers for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 009

Funding Number: RFA RM 19 009
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service Network Hub for Cryoelectron Tomography (U24 - Clinical Trial Not Allowed) Apply for RFA RM 19 010

Funding Number: RFA RM 19 010
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Lipid Signaling in Healthspan and Longevity Regulation (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 039

Funding Number: RFA AG 20 039
Agency: National Institutes of Health
Category: Health
Funding Amount: $250,000
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 19 302

Funding Number: PAR 19 302
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) Apply for PAR 19 301

Funding Number: PAR 19 301
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional) Apply for RFA AG 20 018

Funding Number: RFA AG 20 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $100,000
Implementation Research on Hypertension Control to Prevent Dementia and Cognitive Decline (R61/R33 Clinical Trial Optional) Apply for RFA AG 20 028

Funding Number: RFA AG 20 028
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Apply for PAR 19 304

Funding Number: PAR 19 304
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Apply for PAR 19 305

Funding Number: PAR 19 305
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Regulation of Brain Regional and Cell Type Specific Proteome Dynamics in Alzheimers Disease (R01 Clinical Trial Not Allowed) Apply for RFA AG 20 042

Funding Number: RFA AG 20 042
Agency: National Institutes of Health
Category: Health
Funding Amount: $750,000
Computational Methods for Integrating Tissue and Single Cell Genomic Data from the Brain (R01 Clinical Trial Not Allowed) Apply for RFA MH 20 300

Funding Number: RFA MH 20 300
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Child Neurologist Career Development Program (CNCDP) (K12 Clinical Trial Not Allowed) Apply for RFA NS 19 040

Funding Number: RFA NS 19 040
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 19 297", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: